Home Cart 0 Sign in  
X

[ CAS No. 101385-93-7 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
3d Animation Molecule Structure of 101385-93-7
Chemical Structure| 101385-93-7
Chemical Structure| 101385-93-7
Structure of 101385-93-7 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 101385-93-7 ]

Related Doc. of [ 101385-93-7 ]

Alternatived Products of [ 101385-93-7 ]

Product Details of [ 101385-93-7 ]

CAS No. :101385-93-7 MDL No. :MFCD01631194
Formula : C9H15NO3 Boiling Point : -
Linear Structure Formula :- InChI Key :JSOMVCDXPUXKIC-UHFFFAOYSA-N
M.W : 185.22 Pubchem ID :471360
Synonyms :

Calculated chemistry of [ 101385-93-7 ]

Physicochemical Properties

Num. heavy atoms : 13
Num. arom. heavy atoms : 0
Fraction Csp3 : 0.78
Num. rotatable bonds : 3
Num. H-bond acceptors : 3.0
Num. H-bond donors : 0.0
Molar Refractivity : 51.99
TPSA : 46.61 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.96 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.18
Log Po/w (XLOGP3) : 0.66
Log Po/w (WLOGP) : 0.82
Log Po/w (MLOGP) : 0.45
Log Po/w (SILICOS-IT) : 0.86
Consensus Log Po/w : 0.99

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -1.21
Solubility : 11.5 mg/ml ; 0.0622 mol/l
Class : Very soluble
Log S (Ali) : -1.21
Solubility : 11.3 mg/ml ; 0.061 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -1.11
Solubility : 14.2 mg/ml ; 0.0767 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.96

Safety of [ 101385-93-7 ]

Signal Word:Danger Class:N/A
Precautionary Statements:P261-P264-P270-P271-P280-P301+P312+P330-P302+P352-P304+P340+P312-P305+P351+P338+P310-P332+P313-P403+P233-P405-P501 UN#:N/A
Hazard Statements:H302-H315-H318-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 101385-93-7 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 101385-93-7 ]
  • Downstream synthetic route of [ 101385-93-7 ]

[ 101385-93-7 ] Synthesis Path-Upstream   1~56

  • 1
  • [ 37595-74-7 ]
  • [ 101385-93-7 ]
  • [ 630121-86-7 ]
  • [ 456-64-4 ]
Reference: [1] Patent: US2009/176775, 2009, A1, . Location in patent: Page/Page column 33-34
  • 2
  • [ 101385-93-7 ]
  • [ 3760-52-9 ]
Reference: [1] Patent: US2009/29963, 2009, A1, . Location in patent: Page/Page column 14
[2] Chemistry - A European Journal, 2018, vol. 24, # 55, p. 14836 - 14843
  • 3
  • [ 101385-93-7 ]
  • [ 83220-73-9 ]
  • [ 101469-92-5 ]
YieldReaction ConditionsOperation in experiment
85.3 % ee at 30℃; for 48 h; Microbiological reaction General procedure: The strains selected in the secondary screening were used as biocatalysts in liquid medium for the reduction of cyclic ketones using cyclohexanone as a model substrate by adapting a methodology previously reported [28]. The microorganisms were cultured as mentioned above (see standard growth conditions), and then cyclohexanone (10mM) was added. The reaction was carried out at 30°C in an orbital shaker at 180rpm for 2days. After removing the cells by centrifugation, the supernatants were extracted using ethyl acetate or diethyl ether, and the organic layers were analyzed by Gas Chromatography (GC).
Reference: [1] ChemBioChem, 2018, vol. 19, # 3, p. 239 - 246
[2] Process Biochemistry, 2017, vol. 58, p. 137 - 144
  • 4
  • [ 541-41-3 ]
  • [ 101385-93-7 ]
  • [ 146256-98-6 ]
YieldReaction ConditionsOperation in experiment
85% With sodium hydride In N,N-dimethyl-formamide at 0 - 5℃; for 2.66667 h; 1000ml four-necked flask by adding Boc-pyrrolidone 120g, DMF 600ml, Stirring down to 0-5 , Sodium hydride was added to 26 g, 70.5 g of ethyl chloroformate was slowly added dropwise with stirring, 40min drop finished. 0-5 reaction 2h, TLC detection reaction is completed, Slowly add 3L ice water, With dilute hydrochloric acid to adjust the pH = 7 after ethyl acetate extraction, dry, Concentrated to give intermediate 1. Yield 85percent.
Reference: [1] Patent: CN106905325, 2017, A, . Location in patent: Paragraph 0030-0032
  • 5
  • [ 83220-73-9 ]
  • [ 101385-93-7 ]
YieldReaction ConditionsOperation in experiment
100%
Stage #1: With oxalyl dichloride; dimethyl sulfoxide In dichloromethane at -78℃; for 2.08333 h;
Stage #2: With triethylamine In dichloromethane at -78 - 20℃; for 3 h;
To a cold (-78° C.) solution of oxalyl chloride (2.8 mL, 32.4 mmol) in CH2Cl2 (20 mL) was added DMSO (4.6 mL, 64.8 mmol) in CH2Cl2 (40 mL) and stirred for 5 min at -78° C., followed by the addition of N-Boc-3-pyrrolidinol (4.04 g, 21.6 mmol) in CH2Cl2 (60 mL) and the reaction mixture was stirred for 2 h at -78° C. Triethylamine (15 mL, 108 mmol) was added to the reaction mixture and stirred for 1 h at -78° C. The reaction mixture was warmed to room temperature and stirred for 2 h at room temperature. It was cooled to 0° C. and quenched with saturated NaHCO3 and diluted with ethyl acetate. The organic layer was washed with saturated NaHCO3 and saturated brine. The combined organic layer was dried over MgSO4, filtered and evaporated to give the desired product (4 g, 100percent) that was used without further purification. 1H NMR (400 MHz, CDCl3) δ 3.79-3.75 (m, 4H), 2.58 (t, J=8.0 Hz, 2H), 1.47 (s, 9H).
97% With oxalyl dichloride; dimethyl sulfoxide; N-ethyl-N,N-diisopropylamine In dichloromethane at -60 - 20℃; for 1.5 h; [0356] Part A: To a solution of oxalyl chloride (1.3 mL, 15 mmol) in 20 mL of dichloromethane at -60° C. was added methyl sulfoxide dropwise over period of 10 min. After stirring at -60° C., a solution of 1,1-dimethylethyl 3-hydroxypyrrolidine-1-carboxylate (1.87 g, 10 mmol) in 20 mL of dichloromethane was added over 20 min. Then, diisopropylethylamine (8.8 mL, 50 mmol) was added over 5 min. The resulting mixture was stirred at -60° C. for 25 min, and at room temperature for 30 min. The reaction was diluted with dichloromethane (100 mL). The organic layer was washed sequentially with saturated sodium bisulfate solution (2.x.), saturated sodium bicarbonate solution, water, and brine; dried over sodium sulfate; and concentrated to afford 1.8 g (97percent) of 1,1-dimethylethyl 3-oxo-pyrrolidine-1-carboxylate: 1H-NMR (CDCl3) δ 3.75 (4H, m), 2.58 (2H, t, J=7.8 Hz), 1.49 (9H, s).
97% With Dess-Martin periodane In dichloromethane To a solution of 3-hydroxy-pyrrolidine-1-carboxylic acid tert-b\\xty\\ ester (10 g, 54 mmol) in dichloromethane (300 mL) is added Dess-Martin Reagent (45.9 g, 108 mmol) in three portions. The resulting mixture is stirred for 16 hours. The mixture is filtered through CeIi te and the solvent removed in vacuo. The crude material is purified via silica gel chromatography using a gradient elution of 0-8percent ethyl acetate/hexanes to afford the desired product as a glassy solid (9.8 g, 97percent).
96% With oxalyl dichloride; dimethyl sulfoxide; triethylamine In dichloromethane at -69 - -40℃; for 0.5 h; Inert atmosphere A 3 L, four-necked round-bottomed flask was equipped with a mechanical stirrer, 500 mL addition funnel, cooling bath, K-type thermocouple and a nitrogen inlet.
The flask was charged with oxalyl chloride (149.8 g, 1.18 mol) and dichloromethane (700 mL) and cooled to -69° C.
The stirred solution was treated drop-wise with a solution of dimethyl sulfoxide (99.2 g, 1.27 mol) in dichloromethane (150 mL), maintaining an internal temperature below -60° C. (copious gas generation).
This mixture was briefly warmed to -40° C. before cooling to -69° C. A solution of tert-butyl 3-hydroxypyrrolidine-1-carboxylate (100.0 g, 0.534 mol) in dichloromethane (350 mL) was charged drop-wise to the batch, maintaining an internal temperature below -60° C.
The stirred reaction mixture was allowed to age at -50° C. for 30 minutes and cooled to -69° C. Neat triethylamine (270 g, 2.67 mol) was added drop-wise, while maintaining an internal temperature below -60° C.
Upon completion of the addition, the batch was allowed to age for 30 minutes at -60° C., before warming to ambient temperature over about 1 hour.
The reaction mixture was washed with 5percent mass to volume aqueous citric acid solution (2*180 mL).
The separated aqueous layer was extracted with dichloromethane (2*200 mL), and the combined the organic phases were dried over anhydrous sodium sulfate (30 g), filtered and concentrated under reduced pressure.
The title compound was obtained as a dark brown oily product (95.0 g, 96percent yield) and was used in the next step without further purification.
89%
Stage #1: With oxalyl dichloride; dimethyl sulfoxide In dichloromethane at -78℃; for 0.333333 h;
Stage #2: With triethylamine In dichloromethane at -78 - 20℃; for 2 h;
Oxalyl chloride (6.0 mL, 70.5 mmol) was added to 300 mL of DCM and cooled to - 78°C. DMSO (9.9 mL, 139mmol) was added thereto, and the mixture was stirred for 15 minutes. tert-butyl 3-hydroxypyrrolidin-1-carboxylate (8.98g, 48 mmol) obtained in Step A was added thereto, and the mixture was stirred for 20 minutes. TEA (32 mL, 0.23 mol)was added thereto, and the mixture was stirred at -78°C for 1 hour and addtionally stirred at room temperature for 1hour. After addition of water, the reaction solution was extracted with DCM. The organic layer was dried with MgSO4and purified by column chromatography to obtain the title compound (7.92 g, 89 percent).1H-NMR (CDCl3) δ 3.77 (4H, m), 2.59 (2H, t), 1.48 (9H, s)
71% With pyridinium chlorochromate In dichloromethane at 20℃; N-Boc-3-pyrrolidinol (17.192 g, 0.092 mole) in 50 mL anhydrous methylene chloride was added to a solution of (60 g, 0.276 mole) of pyridinechlorochromate in 300 mL anhydrous methylene chloride which was surrounded by a water bath at room temperature. After stirring at room temperature for 4 hours an additional (60 g, 0.276 mole) of pyridinechlorochromate was added and the reaction was stirred over night. The reaction had gone to completion by the next morning and was diluted with 400 mL diethyl ether and filtered through a pad of celite 521 filter aid using excess diethyl ether to wash through. Evaporation gave a black oil which was flash chromatographed over silica gel eluting with 40percent ethyl acetate in hexane to provide the title compound (12.5 g, 71percent) as an oil.
Mass Spec FD+MI=184.9, (MW=185)
1H NMR (300 MHz CDCl3) δ 1.49 (9H, s); 2.56-2.61 (2H, t); 3.75-3.80 (4H, t).
58% With pyridine-SO3 complex; triethylamine In dimethyl sulfoxide at 20℃; a) 3-Oxo-pyrrolidine-l-carboxylic acid tert-butyl ester In a 1 1 three-necked flask, 10 g of N-Boc-3- hydroxypyrrolidine are dissolved in 350 ml of dimethyl sulphoxide in the presence of 52.3 ml of triethylamine . 28 g of pyridine-sulphur trioxide complex dissolved in 350 ml of dimethyl sulphoxide are added dropwise to the above solution. The reaction mixture is stirred for 4 hours at ambient temperature. The reaction medium is acidified to pH 4.5-5 with a IM solution of hydrochloric acid and the reaction mixture is then extracted with ethyl acetate. The organic phases are combined and then dried over anhydrous sodium sulphate. The residue is filtered through silica gel (1/1 heptane/ethyl acetate) . 5.7 g of 3-oxo-pyrrolidine-l- carboxylic acid tert-butyl ester are obtained. Yield: 58percent.
51% With pyridinium chlorochromate In dichloromethane at 20℃; for 16 h; Pyridinium chlorochromate (481 mmol) was added to a solution of tert-butyl 3-hydroxypyrrolidine-1-carboxylate (160 mmol) in dichloromethane (800 mL) and the reaction mixture was maintained at rt for 16 h. The insoluble solids were removed by filtration and the filtrate was concentrated. The residue was purified by Flash chromatography (20/1 to 10/1 petroleum ether/ethyl acetate) to provide tert-butyl 3-oxopyrrolidine-1-carboxylate in 51percent yield as light yellow oil.

Reference: [1] Patent: US2005/277633, 2005, A1, . Location in patent: Page/Page column 20
[2] Patent: US2004/186134, 2004, A1, . Location in patent: Page 241
[3] Patent: WO2010/5783, 2010, A1, . Location in patent: Page/Page column 151
[4] Patent: US2016/96837, 2016, A1, . Location in patent: Paragraph 0139; 0140
[5] Patent: EP3239143, 2017, A2, . Location in patent: Paragraph 0266
[6] Patent: US2014/66635, 2014, A1, . Location in patent: Paragraph 0033
[7] Patent: US6353008, 2002, B1, . Location in patent: Page column 36
[8] Synthetic Communications, 1985, vol. 15, # 7, p. 587 - 598
[9] Patent: WO2010/63774, 2010, A1, . Location in patent: Page/Page column 23-24
[10] Patent: US2010/29629, 2010, A1, . Location in patent: Page/Page column 66
[11] Journal of Agricultural and Food Chemistry, 1998, vol. 46, # 10, p. 3902 - 3911
[12] Bioorganic and Medicinal Chemistry Letters, 2001, vol. 11, # 20, p. 2691 - 2696
[13] Bioorganic and Medicinal Chemistry Letters, 2004, vol. 14, # 7, p. 1645 - 1649
[14] Bioorganic and Medicinal Chemistry, 2004, vol. 12, # 9, p. 2115 - 2137
[15] Bioorganic and Medicinal Chemistry, 2007, vol. 15, # 2, p. 1022 - 1033
[16] Patent: WO2005/21515, 2005, A2, . Location in patent: Page/Page column 75
[17] Patent: US2005/209249, 2005, A1, . Location in patent: Page/Page column 38
[18] Patent: US2005/215603, 2005, A1, . Location in patent: Page/Page column 39
  • 6
  • [ 83220-73-9 ]
  • [ 101385-93-7 ]
YieldReaction ConditionsOperation in experiment
77.3% With Dess-Martin periodane In dichloromethane at 0 - 20℃; for 0.2 h; Inert atmosphere To a stirred solution of tert-butyl (R)-3-hydroxypyrrolidine-l-carboxylate (Intermediate 8-step 1, 4.5 g, 24.1 mmol) in DCM (60 ml) under N2atmosphere, was added DMP (20.45 g, 48.12 mmol) at 0 °C. The reaction mixture was allowed to room temperature and stirred for about 2 hours. After completion of the reaction (monitored by TLC), the reaction mixture was quenched with 1 : 1 mixture of saturated NaHC03and saturated Na2S203solution. The reaction mixture was extracted with DCM (2x100 ml). The combined organic layer was washed with brine, dried over anhydrous sodium sulphate and concentrated under reduced pressure to give the residue. Purification by column chromatography with EtOAc and hexane (15:85) to afford the desired compound (3.44 g, yield: 77.3percent) as an oil. 1H NMR (300 MHz, CDC13): δ 3.80-3.75 (m, 4H), 2.61-2.56 (m, 2H), 1.48 (s, 9H)
77.3% With Dess-Martin periodane In dichloromethane at 0 - 20℃; for 2 h; Inert atmosphere To a stirred solution of tert-butyl (R)-3-hydroxypyrrolidine-1-carboxylate (4.5 g, 24.1 mmol) in DCM (60 ml) under N2 atmosphere, was added DMP (20.45 g, 48.12 mmol) at 0° C.
The reaction mixture was allowed to room temperature and stirred for about 2 hours.
After completion of the reaction (monitored by TLC), the reaction mixture was quenched with 1:1 mixture of saturated NaHCO3 and saturated Na2S2O3 solution.
The reaction mixture was extracted with DCM (2*100 ml).
The combined organic layer was washed with brine, dried over anhydrous sodium sulphate and concentrated under reduced pressure to give the residue.
Purification by column chromatography with EtOAc and hexane (15:85) to afford the desired compound (3.44 g, yield: 77.3percent) as an oil. 1H NMR (300 MHz, CDCl3): δ 3.80-3.75 (m, 4H), 2.61-2.56 (m, 2H), 1.48 (s, 9H).
34% With pyridine-SO3 complex; triethylamine In dimethyl sulfoxide at 20℃; 1) N-tert-Butoxycarbonyl-3-pyrrolidinone Pyridine-sulfur trioxide (4.12 g) was added to a solution of (3R)-N-tert-butoxycarbonyl-3-hydroxypyrrolidine (2.47 g) and triethylamine (9.19 mL) in dimethylsulfoxide (30 mL) at room temperature, and the resultant mixture was stirred overnight. The reaction solution was poured onto water and extracted with diethyl ether. The organic layer was washed with water and saturated saline, and then dried over anhydrous sodium sulfate. After separation by filtration, a residue obtained by evaporating the solvent under reduced pressure was purified by silica gel column chromatography (ethyl acetate-hexane), to obtain N-tert-butoxycarbonyl-3-pyrrolidinone (855 mg, 34percent) as an oily product. 1H-NMR (400MHz, CDCl3)δ: 1.47(9H, d, J=9.3Hz), 2.59(2H, t, J=7.8Hz), 3.75-3.80(4H, t, J=7.9Hz).
Reference: [1] Patent: WO2017/17630, 2017, A1, . Location in patent: Page/Page column 56
[2] Patent: US2018/237472, 2018, A1, . Location in patent: Paragraph 0166; 0167
[3] Patent: EP1785418, 2007, A1, . Location in patent: Page/Page column 61-62
[4] Organic Process Research and Development, 2017, vol. 21, # 9, p. 1419 - 1422
[5] Patent: EP1550660, 2005, A1, . Location in patent: Page/Page column 9
  • 7
  • [ 101469-92-5 ]
  • [ 101385-93-7 ]
YieldReaction ConditionsOperation in experiment
81% With Dess-Martin periodane In dichloromethane at 0 - 20℃; for 48 h; b) tert-Butyl 3-oxopyrroIidine-l-carboxylate; To a solution of step a) product (10 g, 0.053 mol) in dry CH2Cl2 (200 mL) was added Dess-Martin periodinane (45.3 g, 0.106 mol) at 0 °C under nitrogen arm and stirred at RT for 2 days. To the reaction mixture was added sodium thiosulphate solution and filtered The two layers were separated and the aqueous layer was extracted with CH2Cl2 (2 x 10OmL). The combined organic layers were washed with 10 percent NaHCO3 solution and brine, dried over Na2SO4 and concentrated. The crude product was purified by column EPO <DP n="30"/>chromatography using 30 percent EtOAc in pet. ether. Yield = 8.0 g (81 percent). The product was used directly in step c).
Reference: [1] Patent: WO2007/11284, 2007, A1, . Location in patent: Page/Page column 28-29
[2] Patent: EP3269715, 2018, A1, . Location in patent: Paragraph 0061; 0174; 0175
  • 8
  • [ 775-16-6 ]
  • [ 24424-99-5 ]
  • [ 101385-93-7 ]
Reference: [1] Patent: WO2005/77924, 2005, A1, . Location in patent: Page/Page column 71-72
  • 9
  • [ 146256-98-6 ]
  • [ 101385-93-7 ]
YieldReaction ConditionsOperation in experiment
10.8 g With 2,6-di-tert-butyl-4-methyl-phenol In water; dimethyl sulfoxide; toluene for 6 h; Ethyl N-Boc pyrrolidonecarboxylate (20.0 g) (compound of formula (II) wherein R is Et) was dissolved in toluene (30 ml) and dimethylsulfoxide Mixture and 20 mg of 3,5-di-tert-butyl-4-hydroxytoluene (BHT) was added.The resulting mixture was heated to 115 ° C (internal temperature) and water (4.2 ml, 3.0 eq) was added dropwise over 5 h maintaining the internal temperature at 110-115 ° C.The desired conversion was achieved 1 hour after the water addition was completed.The reaction mixture was cooled to 20 ° C and diluted with water (10 ml).The layers were separated and the aqueous layer re-extracted with toluene (20 ml).The combined organic layers were washed with 20 ml of 5percent w / w aqueous NaCl and then with 10percent w / w NaCl (40 ml) and finally with 20 ml of water.The resulting toluene solution was treated with activated carbon.After filtration, the filtrate was concentrated to dryness to give an orange oil (14 g).Cyclohexane (12 ml) was added at -5 / -10 ° C and the resulting suspension was filtered and washed twice with 3.5 ml of cyclohexane.The solid was dried under vacuum in a 25 ° C oven to give 10.8 g of a white solidbody.The molar yield after separation was 75percent.
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2003, vol. 13, # 24, p. 4399 - 4403
[2] Patent: CN103992258, 2017, B, . Location in patent: Paragraph 0015; 0043; 0052-0061; 0064
  • 10
  • [ 79-37-8 ]
  • [ 83220-73-9 ]
  • [ 101385-93-7 ]
Reference: [1] Patent: EP202048, 1991, B1,
[2] Patent: US4771046, 1988, A,
  • 11
  • [ 79-37-8 ]
  • [ 83220-73-9 ]
  • [ 101385-93-7 ]
Reference: [1] Patent: US6235731, 2001, B1,
  • 12
  • [ 186550-13-0 ]
  • [ 101385-93-7 ]
  • [ 147081-49-0 ]
Reference: [1] Advanced Synthesis and Catalysis, 2008, vol. 350, # 6, p. 807 - 812
  • 13
  • [ 24424-99-5 ]
  • [ 101385-93-7 ]
Reference: [1] Bioorganic and Medicinal Chemistry, 2007, vol. 15, # 2, p. 1022 - 1033
[2] Bioorganic and Medicinal Chemistry Letters, 2004, vol. 14, # 7, p. 1645 - 1649
[3] Bioorganic and Medicinal Chemistry Letters, 2003, vol. 13, # 24, p. 4399 - 4403
[4] Bioorganic and Medicinal Chemistry Letters, 2001, vol. 11, # 20, p. 2691 - 2696
[5] Patent: US2016/96837, 2016, A1,
[6] Patent: WO2017/17630, 2017, A1,
[7] Patent: EP3239143, 2017, A2,
[8] Patent: EP3269715, 2018, A1,
[9] Patent: EP1550660, 2005, A1,
  • 14
  • [ 40499-83-0 ]
  • [ 101385-93-7 ]
Reference: [1] Patent: US2006/189643, 2006, A1, . Location in patent: Page/Page column 9
  • 15
  • [ 775-16-6 ]
  • [ 101385-93-7 ]
Reference: [1] Patent: US2004/29887, 2004, A1,
  • 16
  • [ 24424-99-5 ]
  • [ 101385-93-7 ]
Reference: [1] Angewandte Chemie - International Edition, 2017, vol. 56, # 48, p. 15274 - 15278[2] Angew. Chem., 2017, vol. 129, p. 15476 - 15480,5
  • 17
  • [ 58632-95-4 ]
  • [ 101385-93-7 ]
Reference: [1] Journal of Agricultural and Food Chemistry, 1998, vol. 46, # 10, p. 3902 - 3911
  • 18
  • [ 146256-97-5 ]
  • [ 101385-93-7 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2003, vol. 13, # 24, p. 4399 - 4403
  • 19
  • [ 124-63-0 ]
  • [ 101385-93-7 ]
  • [ 141699-57-2 ]
YieldReaction ConditionsOperation in experiment
63.5% With triethylamine In dichloromethane at 0℃; for 3.5 h; ter^-Butyl 3-[(methyIsulfonyl)oxy]pyrrolidine-l-carboxylate; 5 tert-Butyl 3-hydroxypyrrolidine-l-carboxylate (3.0Og, 16.02mmol) was dissolved in dry DCM (5OmL) and cooled in an ice-water bath. Methanesulfonyl chloride (2.38g, 20.83mmol) was added followed by TEA (2.43g, 24.03mmol) and the reaction mixture was stirred at 0°C for 3.5h. The reaction mixture was washed with water (25OmL) and dried with MgSO4, filtered and evaporated. The crude product was purified using Biotage Horizon HPFC system 10 (40+M column, isocratic run heptane/EtOAc (50:50)) affording the title compund (2.7Og, 63.5percent). 1H NMR (500MHz, CDCl3): 6 1.38 (s, 9H), 2.07 (bs, IH), 2.18 (bs, IH), 2.97 (s, 3H), 3.35-3.61 (m, 4H), 5.16-5.18 (m, IH); 13C NMR (125MHz, CDCl3): δ 28.59, 31.84, 32.76, 38.80, 43.61, 52.16, 80.12, 154.30.
Reference: [1] Patent: WO2006/73366, 2006, A1, . Location in patent: Page/Page column 185
  • 20
  • [ 101385-93-7 ]
  • [ 141699-57-2 ]
Reference: [1] Patent: WO2017/211759, 2017, A1,
  • 21
  • [ 1779-49-3 ]
  • [ 101385-93-7 ]
  • [ 114214-71-0 ]
YieldReaction ConditionsOperation in experiment
51%
Stage #1: With potassium <i>tert</i>-butylate In tetrahydrofuran at 0 - 20℃; for 1 h;
Stage #2: at 0 - 20℃; for 3 h;
1.0 M THF solution of potassium tert-butoxide (2.97 mL, 2.97 mmol) was added to the suspension of methyltriphenylphosphonium bromide (1.11 g, 2.97 mmol) in THF (20 mL) at 0 °C and warmed up to rt for 1 hr. The reaction mixture was cooled back to 0°C and a solution of tert-butyl 3 -oxopyrrolidine- 1 -carboxylate (220 mg, 1.19 mmol) in THF (2 ml) was added. The resulting reaction mixture was warmed to rt over a period of 3 hrs., quenched with saturated NH4C1 (10 ml) and concentrated under reduced pressure. The reaction mixture is extracted with ethyl acetate (100 ml), washed with water, brine, dried (MgSO4), concentrated and the residue was purified by flash silica gel chromatography using a mixture of 15percent ethyl acetate in hexane to provide tert-butyl 3- methylenepyrrolidine-1-carboxylate (110 mg, 0.600 mmol, 51percent yield). ‘H-NMR (400 MHz, CD3OD) ö ppm 5.00 (m, 2H), 3.91 (br. s., 2H), 3.44 (t, J=7.4 Hz, 2H), 2.58 (t, J=6.7 Hz, 2H), 1.46 (s, 9H).
50%
Stage #1: With n-butyllithium In tetrahydrofuran; hexanes at 0℃; for 0.0833333 h;
Stage #2: at 0 - 20℃; for 2.5 h;
Step A: 3-Methylene pyrrolidine-1 -carboxylic acid te/f-butyl ester. To a suspension consisting of methyl triphenylphosphonium bromide (18 g, 51 mmol) and THF (200 ml_) at 0 0C was added n-butyl lithium (1.6 M solution in hexanes, 32 ml_). The resulting orange solution was stirred at 0 °C for 5 min, then a solution of 3-oxo-pyrrolidine-1 -carboxylic acid te/t-butyl ester (9.0 g, 48 mmol) in THF (40 ml_) was added via cannula. The reaction mixture was stirred at 0 °C for 90 min, then warmed to rt and stirring was continued for 1 h. The reaction mixture was then cooled to 0 °C, quenched with sat. NH4CI, and extracted with Et2O. The organic layer was dried (MgSO4) and concentrated. The crude residue was suspended in hot hexanes and filtered. The filtrate was concentrated and purified (FCC) to give the title compound (4.4 g, 50percent).
36% With n-butyllithium In tetrahydrofuran at -78 - 20℃; for 2 h; Inert atmosphere To a solution of PPh3CH3Br (578 g, 1.62 mol) in THF (3.5 L) is added a solution of n-BuLi (600 mL, 1.5 mol) at −78° C. under N2. The mixture is stirred at 0° C. for 1 h then R-2 (200 g, 1.08 mol) in THF (2.0 L) is added to the reaction mixture at 0° C. The mixture is allowed to warm to ambient temperature, stirred for 1 h, then poured into H2O and extracted with EtOAc. The organic layers are washed with brine, dried with Na2SO4, concentrated and purified by flash chromatography (SiO2, Hep to 25percent EtOAc in Hep) to give compound R-3 (70 g, 36percent).
36%
Stage #1: With n-butyllithium In tetrahydrofuran at -78 - 0℃; for 1 h; Inert atmosphere
Stage #2: at 0 - 20℃; for 1 h; Inert atmosphere
[0130] To a solution of PPh3CH3Br (578 g, 1.62 mol) inTHF (3.5 L) is added a solution ofn-Buli (600 mL, 1.5 mol)at -78° C. under N2 . The mixture is stirred at oo C. for 1 h then the solution ofR-2 (200 g, 1.08 mol) in THF (2.0 L) is addedto the reaction mixture at oo C. The mixture is allowed towarm to ambient temperature, stirred for 1 h, then poured intoH20 and extracted with EtOAc. The organic layers arewashed with brine, dried with Na2S04 , concentrated andpurified by flash chromatography (Si02 , Hep to 25percent EtOAcin Hep) to give compound 1-4 (70 g, 36percent ).
36%
Stage #1: With n-butyllithium In tetrahydrofuran at -78 - 0℃; for 1 h; Inert atmosphere
Stage #2: at 0 - 20℃; for 1 h; Inert atmosphere
To a solution of PPh3CH3Br (578 g, 1.62 mol) in THF (3.5 L) is added a solution of n- BuLi (600 mL, 1.5 mol) at -78°C under N2. The mixture is stirred at 0°C for 1 h then R-2 (200 g, 1.08 mol) in THF (2.0 L) is added to the reaction mixture at 0°C. The mixture is allowed to warm to ambient temperature, stirred for 1 h, then poured into H20 and extracted with EtOAc. The organic layers are washed with brine, dried with Na2S04, concentrated and purified by flash chromatography (Si02, Hep to 25 EtOAc in Hep) to give compound R-3 (70 g, 36percent).
33% With potassium <i>tert</i>-butylate In tetrahydrofuran; diethyl ether at 20℃; Inert atmosphere General procedure: To a stirred suspension of methyltriphenylphosphonium bromide (1.5 equiv.) in diethylether(25-45 mL) under argon was added dropwisea solution of potassium-tert-butoxide 1M in THF (1.5 equiv.). The reaction mixture was immediately turned to yellow. After refluxing for 1 hour, the corresponding ketone (1.0 equiv.) was added in portions. The mixture was stirred at room temperature overnight. After completion, the reaction mixture was then hydrolyzed by water (5-8mL). The organic phase was separated and aqueous phase was extracted by diethyl ether (2 x 10mL). The combined organic phases were washed with water (20mLx2), brine (20mLx1), dried over anhydrous MgSO4 and concentrated under reduced pressure to yield crude product. Purification of this crude product by a suitable method afforded the corresponding alkene.

Reference: [1] Journal of Medicinal Chemistry, 2018, vol. 61, # 21, p. 9738 - 9755
[2] Patent: WO2015/35278, 2015, A1, . Location in patent: Page/Page column 81
[3] Patent: WO2010/141809, 2010, A1, . Location in patent: Page/Page column 64
[4] Patent: US2014/45813, 2014, A1, . Location in patent: Paragraph 0110; 0111
[5] Patent: US2014/275014, 2014, A1, . Location in patent: Paragraph 0128; 0129; 0130
[6] Patent: WO2015/116485, 2015, A1, . Location in patent: Page/Page column 24; 25
[7] Tetrahedron Letters, 2015, vol. 56, # 27, p. 4119 - 4123
[8] Patent: US2017/233339, 2017, A1,
  • 22
  • [ 2065-66-9 ]
  • [ 101385-93-7 ]
  • [ 114214-71-0 ]
YieldReaction ConditionsOperation in experiment
61%
Stage #1: With sodium hydride In tetrahydrofuran at 5 - 10℃; for 1 h; Inert atmosphere
Stage #2: at 5 - 20℃; for 12 h; Inert atmosphere
General procedure: Synthesis of substituted alkenes (2) (Scheme I, Step a) [0211] To a suspension of methyl triphenyl phosphonium iodide (50 mmol) in anhydrous THF (100 ml) sodium hydride (75 mmol) was added gradually in the inert atmosphere at 5°C. The reaction mixture was stirred for 1 h at 10°C. After that a solution of corresponding carbonyl compound 1 (45 mmol) in anhydrous THF (20 ml) was added to the reaction mixture at 5°C. The resulting reaction mixture was stirred at room temperature for 12 h. After the reaction was completed, resulting mixture was poured into the water (150 ml) and extracted with dichloromethane (2x70 ml). Organic layer was separated, dried over sodium sulfate and evaporated in vacuo. The residue was purified by column chromatography on silica gel. The yields are specified in Table 2
Reference: [1] Patent: EP2719696, 2014, A1, . Location in patent: Paragraph 0210; 0211
[2] Patent: WO2005/21515, 2005, A2, . Location in patent: Page/Page column 75-76
  • 23
  • [ 101385-93-7 ]
  • [ 114214-71-0 ]
Reference: [1] Patent: US2007/208001, 2007, A1, . Location in patent: Page/Page column 34
  • 24
  • [ 101385-93-7 ]
  • [ 147081-44-5 ]
Reference: [1] ChemCatChem, 2013, vol. 5, # 1, p. 150 - 153
  • 25
  • [ 101385-93-7 ]
  • [ 186550-13-0 ]
Reference: [1] Patent: WO2011/30349, 2011, A1,
  • 26
  • [ 186550-13-0 ]
  • [ 101385-93-7 ]
  • [ 147081-49-0 ]
Reference: [1] Advanced Synthesis and Catalysis, 2008, vol. 350, # 6, p. 807 - 812
  • 27
  • [ 4637-24-5 ]
  • [ 101385-93-7 ]
  • [ 157327-42-9 ]
YieldReaction ConditionsOperation in experiment
83% at 105℃; for 1 h; [00377] Step 1: Synthesis of tert-butyl 3-((dimethylamino)methylene)-4- oxopyrrolidine– 1-carboxylate. A suspension of tert-butyl 3-oxopyrrolidine-1-carboxylate (10 g, 54.05 mmol) in 1,1-dimethoxy-N,N-dimethylmethanamine (120 mL) was stirred at 105°C for 1 h., cooled down to room temperature, the solvent was removed in vacuo and the residue was purified by chromatographic column on silicagel (DCM/MeOH = 60/1 to 20/1) to give tert-butyl 3-((di-methyl- amino)methylene)-4-oxopyrrolidine-1-carboxylate (10.78 g, 83percent yield). ESI-LCMS (m/z): 241.2[M+1]+;1HNMR (400 MHz, CDCl3) δ ppm: 7.26 (s, 1H), 4.57 (s, 2H), 3.86 (s, 2H), 3.09 (s, 6H), 1.48 (s, 9H).
46% at 100℃; for 17 h; Preparation 31
3-Dimethylaminomethylene-4-oxo-pyrrolidine-1-carboxylic acid tert-butyl ester
A solution of tert-butyl 3-oxopyrrolidine-1-carboxylate (25.0 g, 135 mmol), dimethylformamide dimethylacetal (27 mL, 202 mmol) and 1,4-dioxane (170 mL) was heated at 100° C. for 17 hours.
The dioxane was removed in vacuo.
The resulting red solid was triturated with hexanes (180 mL) for one hour, and filtered.
The solid was rinsed with hexanes (2*80 mL) and air dried.
Chromatography on silica gel eluting with dichloromethane:methanol 39:1 then 19:1 to give the title compound (15.04 g, 46percent).
46% at 100℃; for 17 h; Preparation 31
3-Dimethylaminomethylene-4-oxo-pyrrolidine-1-carboxylic acid tert-butyl ester
A solution of tert-butyl 3-oxopyrrolidine-1-carboxylate (25.0 g, 135 mmol), dimethylformamide dimethylacetal (27 mL, 202 mmol) and 1,4-dioxane (170 mL) was heated at 100° C. for 17 hours.
The dioxane was removed in vacuo.
The resulting red solid was triturated with hexanes (180 mL) for one hour, and filtered.
The solid was rinsed with hexanes (2*80 mL) and air dried.
Chromatography on silica gel eluting with dichloromethane:methanol 39:1 then 19:1 to give the title compound (15.04 g, 46percent).
41 g at 105℃; for 0.666667 h; The 3-oxo-pyrrolidine-1-carboxylic acid tert-butyl ester (40g, 216mmol) was dissolved in 300ml DMF-DMA was heated at 105 deg. C 40 minutes. The solution was cooled and evaporated under reduced pressure, hexane was added, and filtered to give an orange solid 41g, and dried, it was used for the next reaction without purification.
41 g at 105℃; for 0.666667 h; (0086) 3-oxopyrrolidine-1-tert-butyl carboxylate (40g, 216mmol) was dissolved in 300mL DMF-DMA, heated for 40 minutes at 105°C. Cooled and concentrated to dry under vacuum, treated with hexane, filtered to obtain orange solid 41g, dried, the product can be used in the reaction of the next step without purification.
4.7 g at 100℃; for 1.5 h; A solution of N-Boc-3-pyrrolidinone (CAS Number 101385-93-7; 5.0 g, 27.0 mmol) in DMF- DMA (32.17 g, 270 mmol) was heated at 100°C for 1.5 h. The resulting mixture was cooled to rt and concentrated under reduced pressure. The obtained residue was triturated with n-pentane (100 ml). The resulting solid was dried under high vacuum yielding tert-butyl 3-((dimethylamino)methylene)-4- oxopyrrolidine-l-carboxylate (4.700 g, 19.58 mmol). LCMS: Method 1, 1.556 min, MS: ES+ 241.43.

Reference: [1] Patent: WO2016/44641, 2016, A2, . Location in patent: Paragraph 00377
[2] Heterocycles, 2002, vol. 56, # 1-2, p. 257 - 264
[3] Patent: US2013/237538, 2013, A1, . Location in patent: Paragraph 0308
[4] Patent: US2013/237537, 2013, A1, . Location in patent: Paragraph 0292-0293
[5] Patent: WO2007/97931, 2007, A2, . Location in patent: Page/Page column 32
[6] Bioorganic and Medicinal Chemistry Letters, 2013, vol. 23, # 19, p. 5361 - 5366
[7] Bioorganic and Medicinal Chemistry Letters, 2015, vol. 25, # 24, p. 5767 - 5771
[8] Patent: CN105622612, 2016, A, . Location in patent: Paragraph 0126; 0127
[9] Journal of Medicinal Chemistry, 2016, vol. 59, # 23, p. 10498 - 10519
[10] Patent: EP3144310, 2017, A1, . Location in patent: Paragraph 0085-0086
[11] Patent: WO2017/158381, 2017, A1, . Location in patent: Page/Page column 73
[12] Patent: US9951069, 2018, B1, . Location in patent: Page/Page column 14-15
  • 28
  • [ 68-12-2 ]
  • [ 101385-93-7 ]
  • [ 157327-42-9 ]
YieldReaction ConditionsOperation in experiment
81.5% With N,N-dimethyl acetamide In tetrahydrofuran for 3 h; Reflux; Heating; Large scale Step (1) 70kg of tetrahydrofuran was added to the 200L reaction vessel, was added 1-tert-butoxycarbonyl-3-pyrrolidinone 6.9kg, then added with DMF-DMA 13.5kg, stirred and heated to reflux for 3 hours, TLC sheet monitoring point, after the reaction, was cooled to room temperature. Concentrated under reduced pressure, and dried to give a reddish brown solid 7.3kg, a yield of 81.5percent; was used directly in the next step.
Reference: [1] Patent: CN105348286, 2016, A, . Location in patent: Paragraph 0049
[2] Patent: CN106543187, 2017, A, . Location in patent: Paragraph 0167-0169
  • 29
  • [ 101385-93-7 ]
  • [ 74-89-5 ]
  • [ 454712-26-6 ]
YieldReaction ConditionsOperation in experiment
92.5%
Stage #1: at 0 - 20℃; for 2 h;
Stage #2: at 20℃; for 1 h;
To a solution of 1-(ferf-butyloxycarbonyl)pyrrolidin-3-one (74 g, 0.4 mol) in MeOH (450 mL) was added an alcohol solution of MeNH2 (137.8 g, 1.2 mol) at O0C, and the resulting mixture was stirred at room temperature for 2 h. Then, NaBH4 (15.2 g, 0.4 mol) was added, and this mixture was stirred at room temperature for another 1 h, then concentrated under reduced pressure to give the residue. This residue was partitioned between CH2CI2 (3 X 500 mL) and water (300 mL). The combined organic layers were dried (Na2SO4), and evaporated to afforded 1-(ferf- butyloxycarbonyl)-3-methylaminopyrrolidine (74 g, 92.5percent), which was used in the next step without purification: 1H NMR (400 MHz, CDCI3) δ ppm 3.54 (m, 4 H), 3.29 (m, 2 H), 2.45 (s, 3 H), 2.20 (m, 1 H), 1.38 (s, 9 H).
52% With 5%-palladium/activated carbon; hydrogen In methanol at 60℃; The mixture of 1 7a (5 g, 27.0 mmol), 30percent of methyl amine in methanol (50 mE) and 5percent Pd/C (500 mg) in methanol (50 mE) was heated at 60° C. under H2 (50 psi) overnight, then cooled and filtered. The filtrate was concentrated under vacuum and the residue was purified by silica gel colunm chromatography (methanol:dichloromethane=1 :40) to provide 17b (2.8 g, 52percent yield). ‘H-NMR (CDC13, 400 MHz):ö=9.99 (s, 1H), 3.79-3.83 (m, 1H), 3.61-3.72 (m, 3H), 3.40 (d, 1H), 2.71 (s, 3H), 2.33-2.36 (m, 2H), 1.75 (s, 9H), EC-MS:201 [M+1]
Reference: [1] Patent: WO2009/76387, 2009, A1, . Location in patent: Page/Page column 42
[2] Patent: US2015/252021, 2015, A1, . Location in patent: Paragraph 0307; 0308
[3] Patent: WO2012/127506, 2012, A1, . Location in patent: Page/Page column 108-109
[4] ChemCatChem, 2018, vol. 10, # 3, p. 510 - 514
[5] Patent: WO2007/122410, 2007, A1, . Location in patent: Page/Page column 101; 106
  • 30
  • [ 101385-93-7 ]
  • [ 365996-87-8 ]
Reference: [1] Patent: WO2006/127530, 2006, A2,
  • 31
  • [ 145100-51-2 ]
  • [ 101385-93-7 ]
  • [ 630121-86-7 ]
YieldReaction ConditionsOperation in experiment
34%
Stage #1: With lithium hexamethyldisilazane In tetrahydrofuran at -78℃; for 1 h;
Stage #2: at -78 - 20℃; for 3.5 h;
Part A:
Tert-butyl 3-(trifluoromethylsulfonyloxy)-2,5-dihydro-1H-pyrrole-1-carboxylate
To a solution of tert-butyl 3-oxopyrrolidine-1-carboxylate (370 mg, 2.0 mmol) in THF (15 ml) at -78° C. was added lithium bis(trimethylsilyl)amide (1M in THF, 2.2 ml, 2.2 mmol) and the reaction solution was stirred for 1 h.
A solution of N-(5-chloropyridin-2-yl)-1,1,1-trifluoro-N-(trifluoromethylsulfonyl)methanesulfonamide (864 mg, 2.2 mmol) in THF (20 ml) was added drop wise.
The reaction mixture was stirred for another 0.5 h and allowed to warm to room temperature over 3 h and quenched with saturated sodium bicarbonate.
The reaction mixture was diluted with ethyl acetate and washed with 15percent potassium hydrogen sulfate, saturated sodium bicarbonate solution, 1 N sodium hydroxide, water and brine.
The combined organic layers were dried over magnesium sulfate and concentrated in vacuo.
Flash chromatography (silica gel, 10percent ethyl acetate/hexane) gave the product as a colorless oil (214 mg, 34percent yield)
Reference: [1] Patent: US2006/235037, 2006, A1, . Location in patent: Page/Page column 60
[2] Patent: WO2010/51245, 2010, A1, . Location in patent: Page/Page column 50
[3] Patent: WO2010/77624, 2010, A1, . Location in patent: Page/Page column 48
  • 32
  • [ 37595-74-7 ]
  • [ 101385-93-7 ]
  • [ 630121-86-7 ]
YieldReaction ConditionsOperation in experiment
62%
Stage #1: With sodium hexamethyldisilazane In tetrahydrofuran at -75℃; for 0.5 h;
Stage #2: at -75 - 0℃;
To a solution of the product from Step A (5.0 g, 27 mmol) in tetrahydrofuran (50 mL) at -75 °C is added a IM solution of sodium hexamethyldisilazane in tetrahydrofuran (50 mL) and the resulting mixture is stirred for 30 minutes. A solution of N-phenyl-bis- trifluoromethansulfonimide (10.7 g, 30.0 mmol) in tetrahydrofuran (100 mL) is then added slowly to the reaction. The mixture is warmed to 0 °C and stirred for 2 hours. Ice-water (100 mL) is added to the reaction mixture and the mixture is diluted with ethyl acetate. The layers are separated and the aqueous layer is extracted with ethyl acetate. The combined organic phase is dried over Νa2SO4, filtered, and the solvent is removed in vacuo. The crude material is purified via neutral alumina chromatography using 10percent ethyl acetate/petroleum ether as the eluent to afford the desired product as an oil (4.0 g, 62percent). MS: 318.38 (M+Η+).
60%
Stage #1: With lithium hexamethyldisilazane In tetrahydrofuran at -78℃; for 0.25 h; Inert atmosphere
Stage #2: at -78 - 30℃; for 4 h; Inert atmosphere
Under nitrogen at -78 , tert-butyl 3-keto-1-carboxylate pyrrolidinone (5.0g, 27mmol) in tetrahydrofuran (50mL) was slowly added dropwise LiHMDS (30mL, 30mmol, 1M in THF) of in tetrahydrofuran (100mL) solution.After addition, the mixture was stirred at this temperature for fifteen minutes, the 1,1,1-trifluoro-phenyl -N- -N - ((trifluoromethyl) sulfonyl) methanesulfonamide (11.35g, 30mmol) in tetrahydrofuran (100mL) was added to the reaction mixture, maintaining the reaction mixture was stirred at -78 3 hours, then raised to 30 for 1 hour. The reaction was washed with sodium bicarbonate solution (10percent, 500mL) was quenched with ethyl acetate ( . 100mL × 2) was extracted and the combined organic phases were washed with brine (100mL × 2) washing the organic phase was dried over anhydrous sodium sulfate, and concentrated to give the crude product by silica gel column chromatography (eluent: petroleum ether / ethyl acetate = 100/1 to 10/1) to give tert-butyl 3 - (((trifluoromethyl) sulfonyl) oxy) -2,5-dihydro-1H - pyrrol-1-carbonate (5.1g, 60percent yield ) as a yellow liquid.
59.8%
Stage #1: With lithium hexamethyldisilazane In tetrahydrofuran at -78℃; for 0.5 h; Inert atmosphere; Cooling with acetone-dry ice
Stage #2: at 0℃; for 2 h;
To an oven dried flask under N2 was added tert-butyl 3-oxopyrrolidine-1-carboxylate (20.0 g, 0.11 mol, 1.0 eq) and THF (200 mL). The solution was cooled in acetone ice bath (-78 ° C.). To that was added LiHMDs (125 mL, 0.12 mol, 1.15 eq) (1 M solution in THF). The reaction mixture was stirred at - 78 °C for 30 mm then added dropwise a solution of 1,1,1-trifluoro-N-phenyl-N- ((trifluoromethyl)sulfonyl)methanesulfonamide (46.3 g, 0.13 mol, 1.2 eq) in THF (200 mL). The reaction mixture was stirred for 30 mm then warmed to 0 °C and stirred for 1.5 h. The reaction mixture was quenched with satd. sodium bicarbonate solution and then extracted with ethyl acetate. The combined extracts were washed with brine, dried over sodium sulfate, filtered and evaporated. The crude product was purified by column chromatography (PE/EA=30/1, v/v) to provide tert-butyl 3- (((trifluoromethyl)sulfonyl)oxy)-2,5 -dihydro- 1H-pyrrole- 1 -carboxylate (20.5 g, 59.8percent).
55.5%
Stage #1: With lithium hexamethyldisilazane In tetrahydrofuran at -78℃; for 0.25 h; Inert atmosphere
Stage #2: at -78 - 0℃; for 2 h;
Step 1.
tert-butyl 3-(((trifluoromethyl)sulfonyl)oxy)-2,5-dihydro-1H-pyrrole-1-carboxylate
To an oven dried flask under N2 was added tert-butyl 3-oxopyrrolidine-1-carboxylate (2 g, 10.8 mmol) and THF (16 mL).
The solution was cooled in acetone ice bath (-78° C.).
To that was added lithium bis(trimethylsilyl)amide (12.96 mL, 12.96 mmol) (1 M solution in THF).
The reaction mixture was stirred at -78° C. for 15 min then added dropwise a solution of 1,1,1-trifluoro-N-phenyl-N-((trifluoromethyl)sulfonyl) methanesulfonamide (4.05 g, 11.34 mmol) in THF (16 mL).
The reaction mixture was stirred for 30 min then warmed to 0° C. and stirred for 1.5 h.
The reaction mixture was quenched with satd.
sodium bicarbonate solution and then extracted with ethyl acetate.
The combined extracts were washed with brine, dried over sodium sulfate, filtered and evaporated.
The crude product was purified by ISCO column (0-30percent EtOAc/heptane) providing tert-butyl 3-(((trifluoromethyl)sulfonyl)oxy)-2,5-dihydro-1H-pyrrole-1-carboxylate (1.9 g, 55.5percent).
53%
Stage #1: With lithium hexamethyldisilazane In tetrahydrofuran at -78℃; for 0.25 h;
Stage #2: at -78 - 20℃;
Step 1
In a 100 mL three-necked flask, a solution of tert-butyl 3-oxopyrrolidine-1-carboxylate (1 g, 5.24 mmol, Eq: 1.00) in THF (30.0 ml) was treated with lithium bis(trimethylsilyl)amide 1M in THF (5.6 ml, 5.6 mmol, Eq: 1.07) at -78° C.
After stirring for 15 min at -78° C., a solution of N-phenylbis(trifluoromethanesulfonimide) (2.27 g, 6.28 mmol, Eq: 1.20) in THF (10 ml) was added by drop.
The reaction mixture was then warmed to room temperature.
The reaction was quenched with the addition of saturated aqueous NaHCO3, and then extracted with ethyl ether.
The organic layer was washed with brine, dried over MgSO4, filtered and concentrated in vacuo.
The crude material was purified by flash chromatography (silica gel, 120 g, 0percent to 30percent EtOAc/Hex gradient) to give 3-trifluoromethanesulfonyloxy-2,5-dihydro-pyrrole-1-carboxylic acid tert-butyl ester (880 mg, 53percent).
49%
Stage #1: With lithium diisopropyl amide In tetrahydrofuran at -78℃; for 2 h;
Stage #2: at -78 - 20℃;
To a solution of tert-butyl 3-oxopyrrolidine-l-carboxylate 1 (5.0 g, 27.0 mmol) in tetrahydrofuran (130 mL) in a three-necked flask was added lithium diisopropylamide (2.0M, 16.2 mL, 32.4 mmol) at -78 °C. After stirring for 2 h at -78 °C, a solution of trifluoro-N-phenyl-N- (trifluoromethylsulfonyl) methanesulfonamide (10.1 g, 28.4 mmol) in tetrahydrofuran (20 mL) was added, and the solution was stirred for another 30 min at this temperature, then warmed to room temperature and stirred for 3 h. Water (30 mL) was added to quench the reaction, and the solution was extracted with ethyl acetate (3 x 200 mL). The organic layers were combined, dried over anhydrous sodium sulfate, filtered and concentrated. The residue was purified by silica gel column chromatography, eluting with petroleum ether to afford the title compound as a brown oil (4.2 g, 49percent).MS (ESI): m/z = 318.1 [M + H]+.
48%
Stage #1: With lithium hexamethyldisilazane In tetrahydrofuran at -78℃; for 0.5 h;
Stage #2: at -78℃; for 4 h;
1-N-Boc-3-pyrrolidinone (1000 mg, 5.40 mmol) was dissolved in THF (10 mL) and chilled to-78°C. 1M LHMDS in THF (9.99 mmol, 9.99 mL) was added slowly (within approx. 10-15 mm). The reaction mixture was stirred for 30 mm. Next 1,1,1-Trifluoro-N-phenyl-N- (trifluoromethyl)sulfonylmethanesulfonamide (2141 mg, 5.99 mmol in THF (20 mL) was added slowly (30 mm). The reaction mixture was stirred for an additional 30 mm at -78 O The acetone bath was replaced with an ice-water bath and the reaction was stirred for anadditional 3h. After quenching the reaction by addition of ice cold water (20 mL), the reaction mixture was transfered to a separatory funnel. EtOAc (100 mL) was added and the organic layer was separated. The water layer was extracted with EtOAc (2 x 30 mL). The organic layer was dried (anh. MgSO4) and evaporated under reduced pressure. The oily residue was dissolved in cyclohexane and injected onto an equilibrated neutral A1203column (5percent EtOAc in cyclohexane). The product was eluted with EtOAc-cyclohexane gradient (5-15percent EtOAc in cyclohexane) and the product containing fraction were concentrated in vacuo to yield the target compound as a yellowish oil (830 mg, 48 percent). LCMS (Method A): RT = 1.81 mi mlz = 262 [M+H-56].1H NMR (500 MHz, CDCI3) O 5.81-5.64 (m, 1H), 4.38-4.14 (m, 4H), 1.48 (5, 9H).
35%
Stage #1: With lithium diisopropyl amide In tetrahydrofuran; n-heptane; ethylbenzene at -78℃; for 0.833333 h;
Stage #2: for 3 h;
To a solution of lithium diisopropylamide (2M in heptane/THF/ethylbenzene, 6.5 mL, 12.96 mmol) in THF (30 mL) at -78° C. was added a solution of N-Boc-3-pyrrolidinone (2 g, 10.8 mmol) in THF (30 mL) over 10 min. After 40 min, a solution of N-phenylbis(trifluoromethanesulfinimide) (4.24 g, 11.88 mmol) in THF (30 mL) was added. After 3 hours, the mixture was quenched with saturated aqueous solution of NaHCO3 and diluted with ethyl ether (250 mL). The aqueous phase was discarded and the organic phase was washed with 5percent citric acid (2.x.50 mL), 10percent aq NaOH (2.x.50 mL), water (50 mL), and brine (50 mL). The organic phase was dried (Na2SO4), filtered and concentrated. The crude product was absorbed on silica gel followed by column chromatography [n-hex/EtOAc (15:1 v/v) followed by n-hex/EtOAc (9:1 v/v)]gave 3-trifluoromethanesulfonyloxy-2,5-dihydro-pyrrole-1-carboxylic acid tert-butyl ester (1.2 g, 35percent) as an oil. 1H NMR (d6-DMSO, 300 MHz) δ1.42 (s, 9H), 4.06-4.26 (m, 4H), 6.02-6.18 (m, 1H); MS (ESI) m/z=262 (MH+-tBu).
34.8%
Stage #1: With lithium hexamethyldisilazane In tetrahydrofuran; toluene at -60℃; for 0.25 h;
Stage #2: at 20℃; for 0.25 h;
1M LHMDS in toluene (30.9 mL, 30.9 mmol) was added to a stirred solution of tert-butyl 3-oxopyrrolidine-1-carboxylate (5.2 g, 28.1 mmol) in THF (75 mL) at -60 °C, stirred for 15 mm, then added a solution of N,N-bis(trifluoromethylsulfonyl)aniline (11.03 g, 30.9 mmol) in THF (25 mL). The mixture was allowed to come to roomtemperature and stirred for 15 minutes. The reaction mixture was diluted with methylene chloride and washed with saturated sodium bicarbonate solution. The organic phase was dried (MgSO4) and concentrated to afford crude product. The crude product was subjected to ISCO flash chromatography (silica gel/hexane-DCM 100:0 to 0:100 gradient) to afford tert-butyl 3 -(((trifluoromethyl)sulfonyl)oxy)-2,5 -dihydro- 1 H-pyrrole1-carboxylate (3.1 g, 34.8percent yield). ‘H NMR (400MHz, chloroform-d) ö 5.96-5.60 (m,1H), 4.44-4.05 (m, 4H), 1.48 (s, 9H).

Reference: [1] Patent: WO2010/5783, 2010, A1, . Location in patent: Page/Page column 151
[2] Patent: TW2016/4185, 2016, A, . Location in patent: Paragraph 0140; 0141
[3] Patent: WO2018/35061, 2018, A1, . Location in patent: Paragraph 0326
[4] Patent: US9242996, 2016, B2, . Location in patent: Page/Page column 68; 69; 70
[5] Patent: US2012/40949, 2012, A1, . Location in patent: Page/Page column 92
[6] Patent: WO2015/48662, 2015, A2, . Location in patent: Page/Page column 58
[7] Patent: WO2018/11570, 2018, A1, . Location in patent: Page/Page column 59
[8] Journal of Medicinal Chemistry, 2014, vol. 57, # 15, p. 6642 - 6652
[9] Patent: US2010/204265, 2010, A1, . Location in patent: Page/Page column 104
[10] Patent: WO2016/65236, 2016, A1, . Location in patent: Page/Page column 124; 125
[11] Bioorganic and Medicinal Chemistry Letters, 2011, vol. 21, # 8, p. 2244 - 2251
[12] Patent: WO2012/127506, 2012, A1, . Location in patent: Page/Page column 69
[13] Patent: WO2017/12576, 2017, A1, . Location in patent: Page/Page column 147; 148
[14] Patent: EP3202765, 2017, A1, . Location in patent: Paragraph 0201; 0202
  • 33
  • [ 37595-74-7 ]
  • [ 101385-93-7 ]
  • [ 630121-86-7 ]
Reference: [1] Patent: WO2012/110773, 2012, A1, . Location in patent: Page/Page column 149; 150
[2] Patent: WO2014/27199, 2014, A1, . Location in patent: Page/Page column 152
[3] Patent: WO2015/100617, 2015, A1, . Location in patent: Page/Page column 49; 50
[4] Patent: WO2018/132905, 2018, A1, . Location in patent: Paragraph 00420; 00423-00424
  • 34
  • [ 37595-74-7 ]
  • [ 101385-93-7 ]
  • [ 630121-86-7 ]
  • [ 456-64-4 ]
Reference: [1] Patent: US2009/176775, 2009, A1, . Location in patent: Page/Page column 33-34
  • 35
  • [ 101385-93-7 ]
  • [ 630121-86-7 ]
Reference: [1] Patent: EP3042907, 2016, A1, . Location in patent: Paragraph 0317; 0318
  • 36
  • [ 101385-93-7 ]
  • [ 476493-40-0 ]
Reference: [1] Patent: WO2017/211759, 2017, A1,
  • 37
  • [ 81290-20-2 ]
  • [ 101385-93-7 ]
  • [ 644970-36-5 ]
Reference: [1] Patent: WO2004/5295, 2004, A1, . Location in patent: Page 158-159
[2] Patent: EP2540728, 2013, A1, . Location in patent: Page/Page column 76
  • 38
  • [ 101385-93-7 ]
  • [ 1194376-31-2 ]
YieldReaction ConditionsOperation in experiment
52%
Stage #1: With sodium hydrogen sulfate In diethyl ether; water at 0℃; for 0.25 h;
Stage #2: at 20℃;
To a solution of 3-Oxo-pyrrolidine-1-carboxylic acid tert-butyl ester (6 g, 32.4 mmol) in H2O/ether (85 mL/60 mL) was added sodium bisulphate (5.06 g, 48.6 mmol) at 0°C, stirred for 15 min and potassium cyanide (3.16 g, 48.6 mmol) was added and stirred at room temperature overnight. The reaction mixture was diluted with EtOAc and washed with water 4 times. The orgnic layer was dried over anhydrous sodium sulphate and concentrated under vacuum. The residue was purified by flash column chromatography (DCM/MeOH::0-3percent) to provide the titled compound (52percent, 3.6 g). LCMS: 13.0(M+H), Rt. 3.2 min, 99.2percent (max).
Reference: [1] Organic Letters, 2015, vol. 17, # 8, p. 1934 - 1937
[2] Patent: WO2015/130905, 2015, A1, . Location in patent: Paragraph 00206
  • 39
  • [ 7677-24-9 ]
  • [ 101385-93-7 ]
  • [ 1194376-31-2 ]
  • [ 942190-60-5 ]
YieldReaction ConditionsOperation in experiment
32.6% With potassium cyanide; 18-crown-6 ether In dichloromethane at 0 - 20℃; for 16 h; Intermediate: tert-butyl 3-cyano-3-hydroxypyrrolidine-1-carboxylate
To a solution of tert-butyl 3-oxopyrrolidine-1-carboxylate (1 g, 5.40 mmol) in DCM (10 mL) was added trimethylsilyl cyanide (0.724 mL, 5.40 mmol), KCN (0.035 g, 0.540 mmol) and 18-CROWN-6 (0.143 g, 0.540 mmol) at 0° C.
The reaction mixture was warmed to rt and stirred at rt for 16 h.
The reaction mixture was cooled to 0° C., and quenched with sat.
NaHCO3, then diluted with EtOAc.
The organic phase was separated, washed with sat.
NaCl, dried over anhydrous Na2SO4, filtered and concentrated.
The residue was purified on silica gel chromatography (0-100percent EtOAc/hex) to yield tert-butyl 3-cyano-3-((trimethylsilyl)oxy)pyrrolidine-1-carboxylate (0.5 g, 1.758 mmol, 32.6percent yield) and tert-butyl 3-cyano-3-hydroxypyrrolidine-1-carboxylate (0.306 g, 1.442 mmol, 26.7percent yield).
tert-butyl 3-cyano-3-((trimethylsilyl)oxy)pyrrolidine-1-carboxylate:
LC/MS (Cond. N-1): [M+H]+ 213.2, RT=4.359 min. 1H NMR (400 MHz, CHLOROFORM-d) 6 ppm 3.83-3.72 (m, 1H), 3.72-3.43 (m, 3H), 2.33 (q, J=6.8 Hz, 2H), 1.52-1.42 (m, 9H), 0.19-0.10 (m, 9H).
Reference: [1] Patent: US2017/107202, 2017, A1, . Location in patent: Paragraph 0452; 0453; 0454; 0455
  • 40
  • [ 773837-37-9 ]
  • [ 101385-93-7 ]
  • [ 1194376-31-2 ]
YieldReaction ConditionsOperation in experiment
4.21 g With sodium hydrogencarbonate In diethyl ether; water at 0 - 20℃; for 24 h; To a stirred solution of N-Boc-3-pyrrolidinone (CAS Number 101385-93-7; 4.0 g, 21.6 mmol) in diethyl ether (50 ml) and water (8 ml) was added NaHC03(3.6 g, 43 mmol) in water (5 ml) at 0°C. NaCN (3.17 g, 64.8 mmol) was added to the reaction mixture at 0°C. The reaction mixture was stirred at rt for 24 h. The resulting reaction mixture was poured into water (500 ml) and extracted with diethyl ether (2 x 300 ml). The combined organic phase was dried over Na2S04, filtered and concentrated under reduced pressure yielding tert-butyl 3-cyano-3-hydroxypyrrolidine-l-carboxylate (4.21 g, 19.9 mmol). This material was used directly for the next step without further purification.1HNMR (400 MHz, DMSO-d6) δ ppm: 6.90 (s, 1 H), 3.48 - 3.63 (m, 2 H), 3.36 - 3.44 (m, 1 H), 3.20 - 3.32 (m, 1 H), 2.27 - 2.33 (m, 1 H), 2.13 - 2.20 (m, 1 H), 1.42 (s, 9 H).
Reference: [1] Patent: WO2017/149313, 2017, A1, . Location in patent: Page/Page column 48
  • 41
  • [ 143-33-9 ]
  • [ 101385-93-7 ]
  • [ 871115-54-7 ]
  • [ 1194376-31-2 ]
Reference: [1] Patent: US2005/277633, 2005, A1, . Location in patent: Page/Page column 20
  • 42
  • [ 67-56-1 ]
  • [ 101385-93-7 ]
  • [ 149-73-5 ]
  • [ 1263283-20-0 ]
Reference: [1] Patent: WO2006/70284, 2006, A1, . Location in patent: Page/Page column 39
  • 43
  • [ 75-16-1 ]
  • [ 101385-93-7 ]
  • [ 412278-02-5 ]
YieldReaction ConditionsOperation in experiment
92% at 20℃; for 1 h; Inert atmosphere To an ice-cold solution of tert-butyl 3-oxopyrrolidine-1-carboxylate (1.0 g, 5.40 mmol) in Et2O (20 mL) was added methylmagnesium bromide (3.50 mL, 10.80 mmol.) drop wise under an inert atmosphere.
The mixture was stirred at RT for 1 h, then quenched with NH4Cl solution followed by extraction with EtOAc (3*100 mL).
The combined organic layers were washed with brine, dried (Na2SO4), filtered and concentrated in vacuo.
Trituration with n-pentane gave i (1.0 g, 92percent).
3-Methylpyrrolidin-3-ol hydrochloride (Precursor 52): To a solution of 4M HCl in 1,4-dioxane (10 mL) at 0° C. was added i (0.850 g, 4.22 mmol) and the mixture stirred for 2 h at RT.
83.8%
Stage #1: With lithium chloride; zinc(II) chloride In tetrahydrofuran; diethyl ether at -10℃; for 1 h;
Stage #2: for 0.5 h;
(2)
Preparation of tert-butyl 3-hydroxy-3-methylpyrrolidine-1-carboxylate
To a 30 L reaction kettle was added 4 L dry THF at -10° C.
After stirring, to the mixture were added ZnCl2 (118 g, 0.86 mol) and LiCl (402 g, 9.5 mol).
After half an hour, to the resulting mixture was slowly added a solution of MeMgBr (3 mol/L) in diethyl ether (6.4 L, 19.2 mol) dropwisely.
The stirring was continued for half an hour.
To the resulting mixture was slowly added a solution of tert-butyl 3-oxopyrrolidine-1-carboxylate (1600 g, 8.6 mol) in THF dropwisely.
After the completion of reaction by HPLC detection, to the system was dropwisely added a saturated NH4Cl solution to quench off the reaction.
The reaction was extracted with ethyl acetate.
The organic phase was washed with a saturated aqueous NaCl solution, dried over anhydrous sodium sulfate, and evaporated to remove the solvent to produce tert-butyl 3-hydroxy-3-methylpyrrolidine-1-carboxylate as a pale yellow solid (1450 g) in a yield of 83.8percent.
83.8% With lithium chloride; zinc(II) chloride In tetrahydrofuran; diethyl ether (2)
Preparation of tert-butyl 3-hydroxy-3-methylpyrrolidine -1-carboxylate
To a 30 L reaction kettle was added 4 L dry THF at -10°C.
After stirring, to the mixture were added ZnCl2 (118g, 0.86mol) and LiCl (402g, 9.5mol).
After half an hour, to the resulting mixture was slowly added a solution of MeMgBr (3mol/L) in diethyl ether (6.4 L, 19.2mol) dropwisely.
The stirring was continued for half an hour.
To the resulting mixture was slowly added a solution of tert-butyl 3-oxopyrrolidine-1-carboxylate (1600g, 8.6mol) in THF dropwisely.
After the completion of reaction by HPLC detection, to the system was dropwisely added a saturated NH4Cl solution to quench off the reaction.
The reaction was extracted with ethyl acetate.
The organic phase was washed with a saturated aqueous NaCl solution, dried over anhydrous sodium sulfate, and evaporated to remove the solvent to produce tert-butyl 3-hydroxy-3-methylpyrrolidine-1-carboxylate as a pale yellow solid (1450 g) in a yield of 83.8 percent.
83.8% With lithium chloride; zinc(II) chloride In tetrahydrofuran; diethyl ether at -10℃; for 0.5 h; (2)
Preparation of tert-butyl 3-hydroxy-3-methylpyrrolidine -1-carboxylate
To a 30 L reaction kettle was added 4 L dry THF at -10°C.
After stirring, to the mixture were added ZnCl2 (118g, 0.86mol) and LiCl (402g, 9.5mol).
After half an hour, to the resulting mixture was slowly added dropwisely a solution of MeMgBr (3mol/L) in diethyl ether (6.4 L, 19.2mol).
The stirring was continued for half an hour.
To the resulting mixture was slowly added a solution of tert-butyl 3-oxopyrrolidine -1-carboxylate (1600g, 8.6mol) in THF dropwisely.
After the completion of reaction by HPLC detection, to the system was dropwisely added a saturated NH4Cl solution to quench off the reaction.
The reaction was extracted with ethyl acetate.
The organic phase was washed with a saturated aqueous NaCl solution, dried over anhydrous sodium sulfate, and evaporated to remove the solvent to produce tert-butyl 3-hydroxy-3-methylpyrrolidine-1-carboxylate as a pale-yellow solid (1450g) in a yield of 83.8 percent.
70% at -78℃; for 4 h; The solution of (0.070 g, 0.38 mmol) tert-butyl 3-oxopyrrolidine-l- carboxylate in anhydrous THF (2 mL) was cooled to -78°C. Then the solution of 1 M methylmagnesium bromide in butyl ether was added dropwise. The reaction was stirred at - 78°C for 4 h and quenched by water (2 mL). After concentrating the reaction in vacuo, the residue was partitioned between ethyl acetate and water. The aqueous layer was extracted once more with ethyl acetate, and the combined organic layers were washed with brine, dried (MgSO4) and concentrated. The residue was purified by silica flash chromatography (gradient elution, using 1 : 1 hexane-ethyl acetate and ethyl acetate) to provide the title compound (0.054 g, 70percent).
69% at 0 - 20℃; for 1 h; EXAMPLE 310 Synthesis of rac-4-((1-benzyl-3-methylpyrrolidin-3-yl)oxy)-5-chloro-2-fluoro-/\/-(thiazol-4-yl)benzenesulfonamide Step 1. Preparation of rac-te/f-butyl 3-hydroxy-3-methylpyrrolidine-1-carboxylate To a cooled (0 °C) solution of te/f-butyl 3-oxopyrrolidine-1-carboxylate (0.975 g, 5.26 mmol) in anhydrous diethyl ether (20 mL)) was added a 3 M solution of methylmagnesium bromide in diethyl ether (3.50 mL, 10.53 mmol). The reaction was allowed to warm to ambient temperature, stirred for 1 hour, and then cooled to 0 °C and quenched by addition of saturated aqueous ammonium chloride (15 mL). The aqueous layer was separated and extracted with ethyl acetate (3 χ 100 mL). The combined organic phases were washed with brine (50 mL), dried with magnesium sulfate, and filtered. Concentration of the filtrate in vacuo and purification of the residue by column chromatography, eluting with a gradient of 0-40percent of ethyl acetate in hexanes, provided the title compound as a yellowish oil (0.735 g, 69percent yield) H NMR (300 MHz, CDCIs) 3.54-3.44 (m, 2H), 3.42-3.33 (m, 1 H), 3.28-3.20 (m, 1 H), 1.93-1.79 (m, 2H), 1.60-1.56 (m, 1 H), 1.46 (s, 9H), 1.42 (s, 3H); MS (ES+) m/z 202.3 (M + 1).
105 mg at 0 - 20℃; for 1 h; 3.0 M ether solution of methylmagnesium bromide (540 .il, 1.62 mmol) wasadded to a solution of tert-butyl 3-oxopyrrolidine-1-carboxylate (100 mg, 0.540 mmol) in THF (2 ml) at 0 °C and warmed up to rt for 1 hr., quenched with saturated NH4C1 (2 ml), extracted with ethyl acetate (60 ml), washed with water, brine, dried (MgSO4) andconcentrated under reduced pressure to provide tert-butyl 3 -hydroxy-3 -methylpyrrolidine1-carboxylate (105 mg) which was used as such for the next step without purification. ‘H NMR (400MHz, CDC13) ö ppm 3.60 - 3.18 (m, 4H), 1.97 - 1.80 (m, 2H), 1.56 - 1.38 (m, 12H).

Reference: [1] Patent: US2013/252938, 2013, A1, . Location in patent: Paragraph 0514
[2] Patent: US2014/45896, 2014, A1, . Location in patent: Paragraph 0134; 0135; 0199; 0200
[3] Patent: EP2703398, 2014, A1, . Location in patent: Paragraph 0119; 0120
[4] Patent: EP2703398, 2014, A1, . Location in patent: Paragraph 0173; 0174
[5] Journal of the American Chemical Society, 2015, vol. 137, # 35, p. 11270 - 11273
[6] Patent: WO2008/24725, 2008, A1, . Location in patent: Page/Page column 123
[7] Patent: WO2017/201468, 2017, A1, . Location in patent: Page/Page column 420-421
[8] Patent: WO2015/35278, 2015, A1, . Location in patent: Page/Page column 87
  • 44
  • [ 101385-93-7 ]
  • [ 74-88-4 ]
  • [ 412278-02-5 ]
YieldReaction ConditionsOperation in experiment
64% With iodine; magnesium In diethyl ether at 0 - 20℃; for 1.5 h; Inert atmosphere To a stirred suspension of magnesium (2.59 g, 106 mmol, 1.97 equiv) in 50 mL of dry ether were added iodine (catalytic) and methyl iodide (6.7 mL, 108 mmol, 2 equiv) slowly drop wise at 0°C under argon atmosphere. This was added to a solution of tert-butyl 3- oxopyrrolidine-1-carboxylate (10 g, 54 mmol, 1 equiv) in 50 mL of ether at 0°C. The reaction mixture was warmed to room temperature and stirred for 1.5 h. After completion, the reactionwas quenched with saturated ammonium chloride solution at 0 °C and extracted with EtOAc. The combined organic extract was dried over sodium sulfate, filtered and concentrated under reduced pressure. Purification using silica gel column chromatography (20percent EtOAc hexanes) afforded 7.0 g of tert-butyl 3-hydroxy-3-methylpyrrolidine-1-carboxylate (Yield = 64percent).
48%
Stage #1: With magnesium In diethyl ether
Stage #2: at 0 - 20℃; for 1.5 h;
Stage #3: With water; ammonium chloride In diethyl ether at 0℃;
c) tert-Bntyl S-hydroxy-S-methylpyrrolidine-l-carboxylate; Methyl magnesium iodide [prepared from magnesium metal (1.73 g, 0.071 mol) and methyl iodide (4.7 mL, 0.074 mol) in dry ether (50 mL)] was slowly added to the solution of step b) product (6.6 g, 0.036 mol) in dry ether (150 mL) at 0 0C under nitrogen atm. The reaction mixture was slowly warmed to RT and stirred for 1.5 h and after cooling to 0 0C, it was quenched with saturated NH4Cl solution. The two layers were separated and the aqueous layer was extracted with ethyl acetate (3xl00mL). The combined organic layers were washed with brine, dried over Na2SO4 and concentrated. The crude product was purified by column chromatography using 40 percent EtOAc in pet. ether. Yield =3.4 g (48 percent). The product was used directly in step d).
Reference: [1] Patent: WO2016/100940, 2016, A1, . Location in patent: Page/Page column 151
[2] Patent: WO2007/11284, 2007, A1, . Location in patent: Page/Page column 29
  • 45
  • [ 917-64-6 ]
  • [ 101385-93-7 ]
  • [ 412278-02-5 ]
Reference: [1] Patent: US2014/45896, 2014, A1, . Location in patent: Paragraph 0081; 0082
  • 46
  • [ 917-64-6 ]
  • [ 101385-93-7 ]
  • [ 921592-91-8 ]
YieldReaction ConditionsOperation in experiment
20%
Stage #1: at -20℃; for 3 h;
Stage #2: With hydrogenchloride In 1,4-dioxane
(1)
Preparation of 3-methylpyrrolidin-3-ol hydrochloride
A solution of tert-butyl 3-carbonylpyrrolidine-1-carboxylate (11.17g, 0.06mol) in THF (45mL) was slowly added to a solution of MeMgI (21.41g, 0.129mol) in diethyl ether.
The reaction was conducted at -20°C under stirring for 3 hours.
A small amount of water was added to the reaction solution.
The resulting reaction solution was filtered by suction.
The filtrate was extracted with dichloromethane.
The organic layer was dried over anhydrous sodium sulfate and filtered.
The filtrate was concentrated to produce a crude product of tert-butyl 3-hydroxy-3-methyl-pyrrolidine-1-carboxylate.
The above crude product was dissolved in 20mL 1,4-dioxane.
To the resulting solution was introduced an HCl gas.
The resulting mixute was stirred overnight and filtered by suction to produce the title product as a red solid (1.67g) in a yield of 20percent (two steps).
Reference: [1] Patent: EP2703398, 2014, A1, . Location in patent: Paragraph 0075; 0076; 0077
  • 47
  • [ 7677-24-9 ]
  • [ 151-50-8 ]
  • [ 101385-93-7 ]
  • [ 942190-60-5 ]
YieldReaction ConditionsOperation in experiment
81% With 18-crown-6 ether In dichloromethane at 0 - 20℃; To a solution of 3-oxo-pyrrolidine-1 -carboxylic acid tert-butyl ester 1W (10 g, 52.3 mmol) in CH2CI2 (150 ml) at 0 0C was added trimethylsilyl cyanide (8.5ml, 63.6 mmol), potassium cyanide (0.34 g, 5.23 mmol) and 18-crown-6 (1.38 g, 5.23 mmol). The reaction mixture was brought to room temperature and stirred overnight. The <n="442"/>reacton mixture was cooled to 0 °C and quenched with saturated NaHCO3 (200 ml).The organic layer was separated, dried over Na2SO4, filtered and concentrated. The . -residue wa^DJjriSed on silica, αel elutinα with 1/8 EtOAc/hexane to αive the desired product 2W (2 g, 81percent).
Reference: [1] Patent: WO2007/70398, 2007, A1, . Location in patent: Page/Page column 439
  • 48
  • [ 7677-24-9 ]
  • [ 101385-93-7 ]
  • [ 942190-60-5 ]
Reference: [1] Patent: WO2010/42850, 2010, A1, . Location in patent: Page/Page column 51; 59
[2] Patent: WO2011/44538, 2011, A1, . Location in patent: Page/Page column 97
[3] Patent: WO2009/67692, 2009, A1, . Location in patent: Page/Page column 44; 146
[4] Patent: WO2010/42851, 2010, A1, . Location in patent: Page/Page column 51; 59
  • 49
  • [ 7677-24-9 ]
  • [ 101385-93-7 ]
  • [ 1194376-31-2 ]
  • [ 942190-60-5 ]
YieldReaction ConditionsOperation in experiment
32.6% With potassium cyanide; 18-crown-6 ether In dichloromethane at 0 - 20℃; for 16 h; Intermediate: tert-butyl 3-cyano-3-hydroxypyrrolidine-1-carboxylate
To a solution of tert-butyl 3-oxopyrrolidine-1-carboxylate (1 g, 5.40 mmol) in DCM (10 mL) was added trimethylsilyl cyanide (0.724 mL, 5.40 mmol), KCN (0.035 g, 0.540 mmol) and 18-CROWN-6 (0.143 g, 0.540 mmol) at 0° C.
The reaction mixture was warmed to rt and stirred at rt for 16 h.
The reaction mixture was cooled to 0° C., and quenched with sat.
NaHCO3, then diluted with EtOAc.
The organic phase was separated, washed with sat.
NaCl, dried over anhydrous Na2SO4, filtered and concentrated.
The residue was purified on silica gel chromatography (0-100percent EtOAc/hex) to yield tert-butyl 3-cyano-3-((trimethylsilyl)oxy)pyrrolidine-1-carboxylate (0.5 g, 1.758 mmol, 32.6percent yield) and tert-butyl 3-cyano-3-hydroxypyrrolidine-1-carboxylate (0.306 g, 1.442 mmol, 26.7percent yield).
tert-butyl 3-cyano-3-((trimethylsilyl)oxy)pyrrolidine-1-carboxylate:
LC/MS (Cond. N-1): [M+H]+ 213.2, RT=4.359 min. 1H NMR (400 MHz, CHLOROFORM-d) 6 ppm 3.83-3.72 (m, 1H), 3.72-3.43 (m, 3H), 2.33 (q, J=6.8 Hz, 2H), 1.52-1.42 (m, 9H), 0.19-0.10 (m, 9H).
Reference: [1] Patent: US2017/107202, 2017, A1, . Location in patent: Paragraph 0452; 0453; 0454; 0455
  • 50
  • [ 101385-93-7 ]
  • [ 73183-34-3 ]
  • [ 212127-83-8 ]
  • [ 1401165-14-7 ]
Reference: [1] Patent: WO2015/100617, 2015, A1, . Location in patent: Page/Page column 50
  • 51
  • [ 101385-93-7 ]
  • [ 212127-83-8 ]
Reference: [1] Patent: WO2015/48662, 2015, A2,
[2] Patent: WO2016/65236, 2016, A1,
[3] Patent: EP3042907, 2016, A1,
[4] Patent: TW2016/4185, 2016, A,
[5] Patent: WO2017/12576, 2017, A1,
[6] Patent: EP3202765, 2017, A1,
[7] Patent: WO2010/5783, 2010, A1,
  • 52
  • [ 1774-47-6 ]
  • [ 101385-93-7 ]
  • [ 301226-25-5 ]
Reference: [1] Patent: WO2013/138210, 2013, A1, . Location in patent: Paragraph 0209
  • 53
  • [ 7677-24-9 ]
  • [ 24424-99-5 ]
  • [ 101385-93-7 ]
  • [ 1067239-08-0 ]
Reference: [1] Patent: WO2011/44498, 2011, A1, . Location in patent: Page/Page column 64-65, 72
[2] Patent: WO2010/132777, 2010, A2, . Location in patent: Page/Page column 46-47; 152-153
  • 54
  • [ 101385-93-7 ]
  • [ 1226781-82-3 ]
Reference: [1] Patent: WO2011/103256, 2011, A1,
[2] Patent: WO2011/37793, 2011, A1,
[3] Organic Process Research and Development, 2015, vol. 19, # 11, p. 1760 - 1768
[4] Patent: US9181262, 2015, B2,
[5] Patent: CN105348286, 2016, A,
[6] Patent: EP3159344, 2017, A1,
[7] Patent: WO2017/81590, 2017, A1,
[8] Patent: TW2017/8222, 2017, A,
[9] Patent: TW2017/8223, 2017, A,
[10] Patent: WO2011/146358, 2011, A1,
  • 55
  • [ 101385-93-7 ]
  • [ 1226781-81-2 ]
  • [ 1226781-82-3 ]
Reference: [1] Organic Process Research and Development, 2015, vol. 19, # 11, p. 1760 - 1768
  • 56
  • [ 101385-93-7 ]
  • [ 1280210-79-8 ]
Reference: [1] Patent: WO2011/103256, 2011, A1,
[2] Patent: WO2011/37793, 2011, A1,
[3] Bioorganic and Medicinal Chemistry Letters, 2013, vol. 23, # 19, p. 5361 - 5366
[4] Patent: EP3144310, 2017, A1,
[5] Patent: EP3159344, 2017, A1,
[6] Patent: WO2017/81590, 2017, A1,
[7] Patent: TW2017/8221, 2017, A,
[8] Patent: TW2017/8222, 2017, A,
[9] Patent: CN106905325, 2017, A,
[10] Patent: TW2017/8223, 2017, A,
[11] Patent: WO2011/146358, 2011, A1,
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 101385-93-7 ]

Amides

Chemical Structure| 14891-10-2

[ 14891-10-2 ]

Ethyl 3-oxopyrrolidine-1-carboxylate

Similarity: 0.92

Chemical Structure| 152533-47-6

[ 152533-47-6 ]

tert-Butyl 2-oxo-7-azabicyclo[2.2.1]heptane-7-carboxylate

Similarity: 0.91

Chemical Structure| 163513-98-2

[ 163513-98-2 ]

(1R,4S)-7-Boc-2-oxo-7-azabicyclo[2.2.1]heptane

Similarity: 0.91

Chemical Structure| 98977-36-7

[ 98977-36-7 ]

1-Boc-3-Piperidinone

Similarity: 0.91

Chemical Structure| 396731-40-1

[ 396731-40-1 ]

tert-Butyl 3,5-dioxopiperidine-1-carboxylate

Similarity: 0.89

Ketones

Chemical Structure| 14891-10-2

[ 14891-10-2 ]

Ethyl 3-oxopyrrolidine-1-carboxylate

Similarity: 0.92

Chemical Structure| 152533-47-6

[ 152533-47-6 ]

tert-Butyl 2-oxo-7-azabicyclo[2.2.1]heptane-7-carboxylate

Similarity: 0.91

Chemical Structure| 163513-98-2

[ 163513-98-2 ]

(1R,4S)-7-Boc-2-oxo-7-azabicyclo[2.2.1]heptane

Similarity: 0.91

Chemical Structure| 98977-36-7

[ 98977-36-7 ]

1-Boc-3-Piperidinone

Similarity: 0.91

Chemical Structure| 396731-40-1

[ 396731-40-1 ]

tert-Butyl 3,5-dioxopiperidine-1-carboxylate

Similarity: 0.89

Related Parent Nucleus of
[ 101385-93-7 ]

Pyrrolidines

Chemical Structure| 14891-10-2

[ 14891-10-2 ]

Ethyl 3-oxopyrrolidine-1-carboxylate

Similarity: 0.92

Chemical Structure| 182352-59-6

[ 182352-59-6 ]

tert-Butyl 2,4-dioxopyrrolidine-1-carboxylate

Similarity: 0.88

Chemical Structure| 73193-55-2

[ 73193-55-2 ]

Ethyl 2-methyl-3-oxopyrrolidine-1-carboxylate

Similarity: 0.85

Chemical Structure| 86953-79-9

[ 86953-79-9 ]

tert-Butyl pyrrolidine-1-carboxylate

Similarity: 0.84

Chemical Structure| 69079-09-0

[ 69079-09-0 ]

Methyl 3-oxopyrrolidine-1-carboxylate

Similarity: 0.84